Cargando…
Co-activation: its association with weakness and specific neurological pathology
BACKGROUND: Net agonist muscle strength is in part determined by the degree of antagonist co-activation. The level of co-activation might vary in different neurological disorders causing weakness or might vary with agonist strength. AIM: This study investigated whether antagonist co-activation chang...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2006
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1665451/ https://www.ncbi.nlm.nih.gov/pubmed/17116259 http://dx.doi.org/10.1186/1743-0003-3-26 |